Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Social Science & Medicine
|
April 1, 1975
The adoption of new drugs by doctors practising in group and solo practice
P M Williamson
The Journal of the Royal College of General Practitioners
|
May 1, 1975
How general practitioners assess risks in using new drugs
P M Williamson
Proceedings of the Australian Association of Neurologists
|
January 1, 1975
Neuromyelitis optica following infectious mononucleosis
P M Williamson
Clinical and Experimental Neurology
|
January 1, 1978
Association of central nervous system sarcoma with familial polyposis coli
P M Williamson, K V Smith
Drug Intelligence & Clinical Pharmacy
|
July 1, 1981
Prescribing restriction: implications and reactions
D J Wolfson, P M Williamson
Clinical and Experimental Neurology
|
January 1, 1977
Syndrome of ophthalmoplegia, ataxia and areflexia
C E Storey, G Selby, P M Williamson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1996
Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans
P M Williamson, J J Kelly, J A Whitworth
Clinical and Experimental Neurology
|
January 1, 1984
Neurological complications of Mycoplasma pneumoniae infection
M A Hely, P M Williamson, T R Terenty
Proceedings of the Australian Association of Neurologists
|
January 1, 1973
Subacute spongioform encephalopathy--a clinical and pathological study with attention to liver involvement
P M Williamson, W H Payne, G Selby, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement
|
November 11, 1998
Cortisol and hypertension
J J Kelly, G Mangos, P M Williamson, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Social Science & Medicine
|
April 1, 1975
The adoption of new drugs by doctors practising in group and solo practice
P M Williamson
The Journal of the Royal College of General Practitioners
|
May 1, 1975
How general practitioners assess risks in using new drugs
P M Williamson
Proceedings of the Australian Association of Neurologists
|
January 1, 1975
Neuromyelitis optica following infectious mononucleosis
P M Williamson
Clinical and Experimental Neurology
|
January 1, 1978
Association of central nervous system sarcoma with familial polyposis coli
P M Williamson, K V Smith
Drug Intelligence & Clinical Pharmacy
|
July 1, 1981
Prescribing restriction: implications and reactions
D J Wolfson, P M Williamson
Clinical and Experimental Neurology
|
January 1, 1977
Syndrome of ophthalmoplegia, ataxia and areflexia
C E Storey, G Selby, P M Williamson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
December 1, 1996
Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans
P M Williamson, J J Kelly, J A Whitworth
Clinical and Experimental Neurology
|
January 1, 1984
Neurological complications of Mycoplasma pneumoniae infection
M A Hely, P M Williamson, T R Terenty
Proceedings of the Australian Association of Neurologists
|
January 1, 1973
Subacute spongioform encephalopathy--a clinical and pathological study with attention to liver involvement
P M Williamson, W H Payne, G Selby, et al.
Clinical and Experimental Pharmacology & Physiology. Supplement
|
November 11, 1998
Cortisol and hypertension
J J Kelly, G Mangos, P M Williamson, et al.
Page
of 4